CAS 785804-17-3

Abarelix (acetate)

Produit contrôlé

CAS : 785804-17-3

Abarelix is a lipoprotein that is used in the treatment of prostate cancer. It modulates protein synthesis by binding to and inhibiting the activity of l-glutamic acid, which is an amino acid that is involved in the production of proteins, including those that are involved in cancer. Abarelix also binds to synthetic polymers, such as polyvinyl alcohol, which may be used for diagnostic purposes. Abarelix has been shown to have anticancer effects with a low toxicity profile in both animal and human trials.

Formule : C₇₄H₉₉ClN₁₄O₁₆

Degré de pureté : Min. 95%

Masse moléculaire : 1,476.1 g/mol

Ref: 3D-KGB80417

Abarelix acetate

CAS : 785804-17-3

Abarelix acetate: synthetic GnRHR antagonist, spikes histamine, lowers LH and testosterone temporarily, used in advanced prostate cancer.

Formule : C₇₂H₉₅ClN₁₄O₁₄·xC₂H₄O₂

Couleur et forme : Solid

Masse moléculaire : 1476.14

Ref: TM-T68701